[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346347-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346347-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","implications-of-linc01094-for-human-malignancies-review","Implications of LINC01094 for human malignancies - Review","","Long non-coding RNAs (lncRNAs) are a major class of non-protein-coding RNAs that regulate multiple tumor-cell biological events, particularly transcription. Dysregulated lncRNA expression can drive carcinogenesis and oncogenesis through inhibitory or oncogenic effects. LINC01094 is a recently identified lncRNA reported to be aberrantly expressed across diverse cancer tissues and to influence several biological processes via competing endogenous RNA (ceRNA) mechanisms, including control of tumor growth, invasion, and migration through PI3K/AKT, PTEN/AKT, and Wnt/β-catenin signaling, as well as transcriptional regulatory networks. The review consolidates documented roles of LINC01094 in malignant cell growth, motility, invasiveness, and metastasis and highlights how these findings may inform experimental and clinical management of human malignancies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/implications-of-linc01094-for-human-malignancies-review/346347/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/implications-of-linc01094-for-human-malignancies-review/346347.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is LINC01094 and why is it important in cancer research?","Question",{"text":63,"@type":64},"LINC01094 is a recently identified long non-coding RNA reported to be dysregulated across multiple cancer tissues. It influences cancer-related biological processes and is linked to malignant behaviors such as growth, invasion, and migration.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does LINC01094 affect tumor cell growth, invasion, and migration?",{"text":68,"@type":64},"LINC01094 functions as a competing endogenous RNA (ceRNA). It modulates tumor cell phenotypes by regulating signaling pathways including PI3K/AKT, PTEN/AKT, and Wnt/β-catenin, and also via transcriptional regulatory networks.",{"name":70,"@type":61,"acceptedAnswer":71},"What does the review aim to achieve regarding human malignancies?",{"text":72,"@type":64},"The review summarizes cancer biology functions of LINC01094 reported in published literature. It aims to support innovation in the laboratory and clinical management of human malignancies by clarifying how LINC01094 contributes to malignant progression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346347,1790095477,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Submitted 9 April 2025  \nAccepted 29 November 2025  \nPublished 27 January 2026 Corresponding author Xiangyong Li, [xyli75@126.com](xyli75@126.com)[ ](xyli75@126.com)Academic editor  \nHilal Ozdag  \nAdditional Information and Declarations can be found on page 11  \nDOI 10.7717/peerj.20621  \n Copyright 2026 Wang et al.  \nDistributed under  \nCreative Commons CC-BY 4.0  \nOPEN ACCESS  \nImplications of LINC01094 for human malignancies  \nYan Wang1 ,2 ,* , Yang Yang1 ,3 ,* , Quanying Zhang1 ,3 , Ying Zeng4 , Yilin Cai4 , Haiqing Luo4 and Xiangyong Li1  \n1 Institute of Biochemistry and Molecular Biology, Guangdong Medical University, Zhanjiang, Guangdong, China  \n2 Key Laboratory of Liver Injury Diagnosis and Repair and Department of Hepatobiliary Surgery, The 2nd Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China  \n3 School of Medical Technology, Guangdong Medical University, Dongguan, Guangdong, China  \n4 Cancer Hospital of The Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China  \n* These authors contributed equally to this work.  \nABSTRACT  \nLong non-coding RNAs (lncRNAs) constitute a large class of ribonucleic acids, participating in multiple biological events within tumor cells, especially the regulation of transcription. A growing body of literature has revealed that abnormalities of lncRNA expression could result in carcinogenesis and oncogenesis by exerting inhibition or oncogenic effects. LINC01094 is a recently identified lncRNA found to be dysregulated in an assortment of cancer tissues and control multiple biological processes via competing endogenous RNA (ceRNA) mechanisms. Specifically, LINC01094 functions as a ceRNA to modulate tumor cell growth, invasion, and migration by regulating critical signaling pathways including PI3K/AKT, PTEN/AKT, and Wnt/􀀌-catenin, while also exerting oncogenic effects through transcriptional regulatory networks. Numerous recently published reports have shown that LINC01094 exerts critical functions during the regulation of malignant cell growth, migrating ability, and invasiveness, thereby controlling cancer cell growth and metastasis. In this review, multiple cancer biology functions of LINC01094 documented in published literature are summarized, aiming to inspire innovations in the management of human malignancies under laboratory and clinical settings.  \nSubjects Biochemistry, Cell Biology, Immunology, Oncology, Pathology Keywords Cancers, Clinical characteristics, Growth and metastasis, LINC01094, Molecular mechanisms  \nINTRODUCTION  \nOver the past decades, neoadjuvant therapy (NAT)􀀖encompassing chemotherapy, radiotherapy, and immunotherapy􀀖has revolutionized cancer treatment by improving response rates and surgical outcomes ( Yuan et al., 2025) . However, substantial challenges persist in enhancing patients' quality of life, prolonging survival, and mitigating late-stage recurrence. These limitations underscore the urgent need to decipher the molecular mechanisms underlying cancer cell heterogeneity. Therefore, it is crucial to further elucidate the molecular andcellular mechanisms responsible for these unique features of cancerous cells to facilitate improvements in cancer diagnosis and treatment. Recently,  \nHow to cite this article Wang Y, Yang Y, Zhang Q, Zeng Y, Cai Y, Luo H, Li X. 2026. Implications of LINC01094 for human malignancies. PeerJ 14:e20621 [http://doi.org/10.7717/peerj.20621](http://doi.org/10.7717/peerj.20621)  \nthe implications of non-coding RNAs (ncRNAs) for carcinogenesis and oncogenesis, as well as the underlying molecular mechanisms, have increasingly attracted research interest. NcRNAs are RNAs that do not encode protein products that exert crucial biological and cancerogenesis-related functions (Anastasiadou, Jacob & Slack, 2018; Esteller, 2011) . Generally, ncRNAs are divided into circular RNA and linear RNA according to their structure, and those with a linear structure can be further divided into long n","cbCaipYq74qyQNiO","https://ap.wps.com/l/cbCaipYq74qyQNiO","pdf",10211647,17,"English","# Abstract\n# Introduction\n## Overview of neoadjuvant therapy and cancer heterogeneity\n## Non-coding RNAs and lncRNA classification\n## Dysregulated lncRNAs in carcinogenesis\n# LINC01094 description and genomic context\n# Biological roles and mechanisms (ceRNA and signaling pathways)","[{\"question\":\"What is LINC01094 and why is it important in cancer research?\",\"answer\":\"LINC01094 is a recently identified long non-coding RNA reported to be dysregulated across multiple cancer tissues. It influences cancer-related biological processes and is linked to malignant behaviors such as growth, invasion, and migration.\"},{\"question\":\"How does LINC01094 affect tumor cell growth, invasion, and migration?\",\"answer\":\"LINC01094 functions as a competing endogenous RNA (ceRNA). It modulates tumor cell phenotypes by regulating signaling pathways including PI3K/AKT, PTEN/AKT, and Wnt/β-catenin, and also via transcriptional regulatory networks.\"},{\"question\":\"What does the review aim to achieve regarding human malignancies?\",\"answer\":\"The review summarizes cancer biology functions of LINC01094 reported in published literature. It aims to support innovation in the laboratory and clinical management of human malignancies by clarifying how LINC01094 contributes to malignant progression.\"}]","Implications of LINC01094 for human malignancies - Review | PDF",1790060992,43,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7b5c7f5ccfbac6e91b2dd9767cdaaa4.webp",983,1272,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2f70ddccb17ff2204347a536e8102129.webp",982,1270,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b191ec3f0ee707d628ff5bfd6b1bf81.webp",981,1269,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e555e1182d914524698271e0fc6352f2.webp",980,1268]